2025 Congress Program

Saturday 30th August 2025

Full program details for each meeting is available on their dedicated event page. Click the event to view full details.

0800 – 1800	Registration
Room	River View Room 4	Meeting Room 1	Meeting Room 2
0845 – 1000	Continuing Medical Education (CME) Course		KidGen Symposium
1030 – 1100	Morning Tea and Exhibition
1100 – 1230	Continuing Medical Education (CME) Course		KidGen Symposium
1230 – 1315	Lunch and Exhibition
1315 – 1445	Continuing Medical Education (CME) Course	Interventional Nephrology Workshop	KidGen Symposium
1445 – 1515	Afternoon Tea and Exhibition
1515 – 1645	Continuing Medical Education (CME) Course	Interventional Nephrology Workshop	KidGen Symposium
1645 – 1830	CME Course x INW Networking Event \| Meeting Room 1 – 3 Foyer, Level 2, PCEC

Sunday 31st August 2025

Full program details for each meeting is available on their dedicated event page. Click the event to view full details.

0800 – 1700	Registration
Room	River View Room 4	Meeting Room 1	Meeting Room 2	Meeting Room 3	Meeting Room 9
0845 – 1030	Continuing Medical Education (CME) Course	Interventional Nephrology Workshop	Consumer & Carers Day	Renal Nutrition Update Day
1030 – 1100	Morning Tea and Exhibition
1100 – 1230	Continuing Medical Education (CME) Course	Interventional Nephrology Workshop	Consumer & Carers Day	Renal Nutrition Update Day	Kidney Scientist Workshop
1230 – 1315	Lunch and Exhibition
1315 – 1445	Continuing Medical Education (CME) Course	Interventional Nephrology Workshop	Consumer & Carers Day	Renal Nutrition Update Day	Kidney Scientist Workshop
1445 – 1515	Afternoon Tea and Exhibition
1515 – 1645	CME Course X Renal Nutrition Update Combined Session		Consumer & Carers Day	Renal Nutrition Update Day X CME Course Combined Session (River Room 4)	Kidney Scientist Workshop
1645 – 1900	Cultural Welcome \| Lawn Area, Level 2, PCEC followed by Congress Welcome Reception \| BelleVue Room 1, Level 3, PCEC Entertainment from the Wyvern Big Band Wyvern Big Band is a traditional Big Band/Jazz Orchestra comprising of Wesley College Alumni and community members. It was founded in 1996 by Neville Bird as a means for former Wesley and Penrhos students to continue to enjoy music after they graduated from school. Over the years, there have been a number of people who have played in the band, ranging from cool cats on the Perth and even International Jazz scene, a couple of father and sons, and currently we have five doctors (including 2.5 Nephrologists) and a dentist in the line up.The band plays a wide variety of music, ranging from traditional standards from Basie, Ellington, Miller and Sinatra etc…, through to more modern numbers including some rock/pop numbers with a twist. As the band prepares to celebrate it’s 30th anniversary next year, Wyvern Big Band are delighted to be showcasing their musical talents at the 60th ANZSN Congress.
1930 – 2230	President’s Dinner (invitation only)

Monday 1st September 2025

0645 – 0815	Novo Nordisk Breakfast Symposium
Room	Meeting Room 1 – 2
	Diabetic Kidney Disease Advancing metabolic, cardiovascular and kidney health in people with diabetes and CKD: An endocrinology and nephrology perspective Join professors Richard MacIsaac and Meg Jardine for a dynamic breakfast session that delves into the complex interplay between cardiovascular disease, chronic kidney disease (CKD), and diabetes. Emphasizing a multidisciplinary approach that bridges endocrinology and nephrology, this engaging event will provide the latest clinical updates, explore innovative therapies, and incorporate real-world patient perspectives. Through expert commentary and forward-thinking dialogue, the session will spotlight evolving treatment paradigms and patient-centred strategies that are shaping the future of care for individuals with diabetic kidney disease.
0730 – 1700	Registration
0830 – 1000	PLENARY #1: Congress Opening Session
Room	BelleVue Ballroom 2
Session Chair/s	Professor Rathika Krishnasamy
0830 – 0900	Congress Welcome & President’s Address Professor Rathika Krishnasamy
0900 – 1000	Plenary Speaker MUSINGS ABOUT NEPHROLOGY PAST, PRESENT AND EMERGING Professor Adeera Levin, University of British Columbia
1000 – 1030	Morning Tea, Exhibition and Poster Viewing
1010 – 1025	Medison Knowledge Hub Presentation \| BelleVue Room 1 Update in the Diagnosis and Treatment of Primary Hyperoxaluria Dr Thomas ForbesDr Forbes is the Director of Nephrology and the Royal Children’s Hospital in Melbourne and a Clinician Scientist at the Murdoch Children’s Research Institute. His clinical and research interests include genetic kidney disease and primary hyperoxaluria. Dr Forbes will present an overview and update of the genetics and epidemiology of primary hyperoxaluria, the existing treatment strategies and the future of treatment with novel RNA inhibitor therapies.
1030 – 1200	CONCURRENT SESSION #1
Stream	Symposium – Glomerular Disease	Mini Orals: Consumer Involvement, Indigenous Health Advancement & Environmental Sustainability and Green Nephrology	Mini Orals: Haemodialysis – Haemodialysis – Vascular Access, CKD-MBD/Anaemia/Adequacy & Haemodialysis – Other	Early Career Award Session
Room	BelleVue Ballroom 2	Meeting Room 1	Meeting Room 2	Meeting Room 3
Session Chair/s	Prof. Richard Kitching & Dr Kate Robson	Dr Carla Scuderi & Dr Reva Manickavasagar	Dr Ashley Irish & Casey Light	Prof. Natasha Rogers & Dr Drew Henderson
1030 – 1045	A NEW TREATMENT PARADIGM FOR IGA NEPHROPATHY- THE BRAVE NEW WORLD Professor Jonathan Barratt, University of Leicester	FROM APP TO EFFECT: THE CONSUMER’S JOURNEY IN THE TELEKINESIS STUDY Joanne Beer	A VEIN ATTEMPT? DEVELOPING A MACROFLUIDIC MODEL OF ARTERIOVENOUS FISTULAS TO STUDY FLOW-MEDIATED ENDOTHELIAL CELL SIGNALLING Nasir Ali Shah	TARGETING MITOCHONDRIAL REACTIVE OXYGEN SPECIES TO INHIBIT NETS: SKQ1’S POTENTIAL IN AUTOIMMUNE KIDNEY VASCULITIS THERAPY Andre Espiritu
		CO-DESIGNING ADOLESCENT AND YOUNG ADULT (AYA) KIDNEY CARE IN AN ADULT HOSPITAL SETTING Monica Suet Ying Ng Holly Mchenery-Wakelin	PATIENTS WITH CHRONIC KIDNEY DISEASE HAVE ACCELERATED MICROARCHITECTURAL BONE DETERIORATION Vanitha Nagarajah
1045 – 1100		COPRODUCTION AND TRANSLATING EVIDENCE INTO PRACTICE AND POLICY IN KIDNEY DISEASE: PERSPECTIVES OF STAKEHOLDERS IN AUSTRALIA AND NEW ZEALAND Dale Coghlan	A RISING CLUSTER OF ERYTHROPOIETIN-ASSOCIATED PURE RED CELL APLASIA & SUBSEQUENT RESPONSE TO ROXADUSTAT – A CASE SERIES Jayana Devathasan	PREVALENCE OF CARDIOVASCULAR-KIDNEY-METABOLIC MULTIMORBIDITY IN AUSTRALIAN PRIMARY CARE: ESTIMATES FROM A NATIONAL GENERAL PRACTICE DATASET Jeffrey Ha
		SYSTEMATIC REVIEW OF RESEARCH PRIORITY SETTING IN KIDNEY DISEASE Dale Coghlan	UNDERSTANDING HAEMODIALYSIS ACUITY IN WESTERN AUSTRALIA: A STATEWIDE CROSS-SECTIONAL ANALYSIS TO GUIDE CLINICAL DECISION-MAKING AND SERVICE PROVISION James Cohen
1100 – 1115	LUPUS NEPHRITIS – UP CLOSE AND PERSONAL(ISED) Professor Liz Lightstone, Imperial College London	CODESIGNING WITH OLDER CONSUMERS NEW RESOURCES TO SUPPORT INFORMED DECISIONS ABOUT MANAGEMENT OF KIDNEY FAILURE USING DATA FROM THE CKD.TASLINK STUDY Matthew Jose	FRAILTY AND REMOTENESS DRIVE HIGH PATIENT ACUITY IN HAEMODIALYSIS: A CROSS-SECTIONAL STUDY IN WESTERN AUSTRALIA James Cohen	JUN EXPRESSION IN MYELOID CELLS PROTECTS AGAINST LPS-INDUCED INFLAMMATION AND ISCHAEMIA-REPERFUSION INJURY Dr Priyanka Subramani
		CAPE YORK KIDNEY CARE – REDUCING DIALYSIS IN WESTERN CAPE YORK Andrea Miller	CHARACTERISING THE CONTEMPORARY HAEMODIALYSIS POPULATION IN FIJI Ben Talbot
1115 – 1130		PARTNERSHIP THROUGH GOVERNANCE- A METHODOLOGY FOR LONG-TERM FOLLOW-UP OF ABORIGINAL AND TORRES STRAIT ISLANDER PARTICIPANTS OF THE EGFR COHORT STUDY JT Hughes Sian Graham	PRACTICE PATTERNS, BARRIERS, AND FACILITATORS OF VACCINATION IN HAEMODIALYSIS RECIPIENTS: A NATIONAL CLINICIAN SURVEY Erin Vaughan	MAINSTREAMING GENOMICS IN NEPHROLOGY- RESULTS OF A NEW MODEL OF CARE IN VICTORIA Kushani Jayasinghe
		INDIGENOUS DATA GOVERNANCE AS ACTIVE AND ENDURING RESEARCH PROCESS: THE EGFR3 STUDY JT Hughes Sian Graham	BARIATRIC SURGERY AND ITS EFFECT ON HAEMODIALYSIS: A RETROSPECTIVE COHORT STUDY Nicharee Sangdurn
1130 – 1145	INTEGRATION OF GENETIC TESTING IN PATIENTS WITH GLOMERULAR DISEASE PRESENTATION Dr Janewit Wongboonsin, Siriraj Hospital, Mahidol University, Thailand and Brigham and Women’s Hospital, Boston, USA	WHAT OUR FAMILY AND COMMUNITY MUST KNOW- CARING FOR LONG TERM KIDNEY HEALTH: EGFR3 STUDY JT Hughes Sian Graham	HAEMODIAFILTRATION AT HOME: SINGLE CENTRE EXPERIENCE WITH SAFETY, EFFICACY, AND IMPLEMENTATION Maddison Taylor	BONE MARROW-MSCs EXPRESSING ANTI-FIBROTIC CARGO INDUCE ANTI-HYPERTENSIVE AND ANTI-FIBROTIC EFFECTS IN HYPERTENSIVE NON-HUMAN PRIMATES Chen Wei
		SCOPING REVIEW OF THE CLIMATE FOOTPRINT OF DIALYSIS Kelly Lambert	THE DYNAMICS OF SARCOPENIA AND FRAILTY Limy Wong
1145 – 1200		THE CARBON FOOTPRINT OF DIALYSIS THERAPIES IN AUSTRALIA Ben Talbot	TWICE-WEEKLY HAEMODIALYSIS IN A TERTIARY KIDNEY SERVICE IN REGIONAL AUSTRALIA Jeffrey Ha	A CROSS-SECTIONAL STUDY INVESTIGATING THE ASSOCIATION BETWEEN URAEMIC TOXINS AND PATIENT-FOCUSED OUTCOMES Aruni Malaweera
		Mini Oral Buffer	Mini Oral Buffer
1200 – 1300	Lunch, Exhibition and Poster Viewing
1215 – 1255	PEErusing Posters – Exploring the Poster Paddock All authors stand by posters to answer delegate questions A guided tour of the amazing work presented at the 2025 ANZSN Congress
1300 – 1500	PLENARY #2: Young Investigator Award Session
Room	BelleVue Ballroom 2
Session Chair/s	Prof. Melinda Coughlan & Dr Samantha Bateman
1300 – 1315	HUMAN MPO-ANCA FROM PEOPLE WITH ACUTE MPO-AAV IS VARIABLY PATHOGENIC IN VITRO AND IN VIVO Minh Huan Dang
1315 – 1330	DIAGNOSTIC UTILITY OF GENETIC TESTING IN KIDNEY DISEASE OF UNCERTAIN CAUSE (UKD) Julia Jefferis
1330 – 1345	HIGHLY PREVALENT A20 VARIANTS DRIVE TOLL-LIKE RECEPTOR-MEDIATED KIDNEY DISEASE IN INDIGENOUS AUSTRALIANS Tom Lea-Henry
1345 – 1400	IMPACT OF PREFORMED DONOR SPECIFIC ANTIBODIES (DSA) ON REJECTION, ALLOGRAFT SURVIVAL AND MORTALITY IN AUSTRALIAN KIDNEY TRANSPLANT RECIPIENTS: AN ANZDATA AND ORGANMATCH ANALYSIS Paayal Naidu
1400 – 1415	TSP1 BLOCKADE AND ACE INHIBITION ATTENUATE CARDIAC REMODELLING IN MICE Katie Trinh
1415 – 1430	KIDNEYVISION – MORPHOMETRIC ANALYSIS TOOLS FOR KIDNEY BIOPSY Daniel Christiadi
1430 – 1445	NON-INVASIVE ASSESSMENT OF URINARY EXFOLIATED PROXIMAL TUBULE CELLS USING MULTISPECTRAL AUTOFLUORESCENCE IMAGING AND MACHINE-LEARNING TO IDENTIFY BETWEEN HISTOPATHOLOGICAL CAUSES OF KIDNEY TRANSPLANT COMPLICATIONS Henry HL Wu
1445 – 1500	REMOTE BLOOD PRESSURE MONITORING IN WOMEN AT HIGH RISK OF PREECLAMPSIA – A RANDOMISED CONTROLLED TRIAL (REMOTE CONTROL TRIAL) Theepika Rajkumar
1500 – 1530	Afternoon Tea, Exhibition and Poster Viewing
1500 – 1530	Novartis Knowledge Hub Presentation \| BelleVue Room 1 Uncovering the Patient Journey: The Lived Experience and Psychosocial Impact of C3G in Australia C3 glomerulopathy (C3G) is an ultra-rare, progressive kidney disease driven by dysregulation of the alternative complement pathway, with a high lifetime risk of kidney failure and post-transplant recurrence. Despite its severity, C3G remains under-recognised and underdiagnosed, with no approved targeted therapies and no clear disease management guidelines. This session will explore the lived experience of Australian patients with C3G, focusing on diagnostic delays, psychosocial burden, and care gaps. Qualitative insights will highlight the impact of C3G on mental health, education, employment, and transitions in care. The session aims to raise awareness among nephrologists of the urgent unmet needs and inform multidisciplinary approaches to improve patient outcomes.
1530 – 1700	CONCURRENT SESSION #2
Stream	Symposium – Cardiovascular Health	Mini Orals: General Nephrology – Epidemiology and Public Health & Transplantation	Mini Orals: General Nephrology – Acute Kidney Injury, Glomerulonephritis & Experimental Tubulointerstitial Disease	Kidney Health Australia (KHA) Award Session
Room	BelleVue Ballroom 2	Meeting Room 1	Meeting Room 2	Meeting Room 3
Session Chair/s	A/Prof. Renuka Shanmugalingam & Dr Thomas Evans	Dr Alison Weightman & Dr Ben Lazarus	A/Prof. Jagaish Jamboti	Dr Jennifer Yo & Prof. Brendan Murphy
1530 – 1600	STRUCTURAL BASIS OF AGONISM AND ANTAGONISM AT THE MINERALOCORTICOID RECEPTOR Professor Peter Fuller, Hudson Institute of Medical Research	THE RISE AND RISE OF CHRONIC KIDNEY DISEASE IN REGIONAL, RURAL AND REMOTE COMMUNITIES. A STATEWIDE REPORT USING DATA LINKAGE Matthew Jose	ADDITIVE VALUE OF URINE KIDNEY INJURY MOLECULE (KIM) -1 IN A HIGH-RISK COHORT FROM THE EMERGENCY DEPARTMENT: A SINGLE CENTER PROSPECTIVE COHORT STUDY Nila Kirubakaran	Time: 1530 – 1541 COMMUNITY-GUIDED REPORTING OF KIDNEY FAILURE INCIDENCE AMONG TORRES STRAIT ISLANDER PEOPLE IN AUSTRALIA: 2004-2022 Shahid Ullah
		GAIT SPEED AND GRIP STRENGTH FOR RISK STRATIFYING ESTIMATED GLOMERULAR FILTRATION RATE IN COMMUNITY-DWELLING OLDER ADULTS Elisa Bongetti	ONCO-NEPHROLOGY AND AKI: CANCER AND NON-CANCER PATIENT OUTCOMES AFTER AKI IN HOSPITAL Claire Johnston	Time: 1541 – 1552 INEQUITIES IN ACCESS TO LIVING DONOR KIDNEY TRANSPLANTATION IN AUSTRALIA: A 17-YEAR NATIONAL COHORT STUDY Melanie Wyld
1545 – 1600		COMPARISON OF CREATININE-BASED GLOMERULAR FILTRATION RATE ESTIMATING EQUATIONS IN OLDER ADULTS Elisa Bongetti	ACUTE KIDNEY INJURY ASSOCIATED WITH IMMUNE-CHECKPOINT INHIBITORS IN CANCER PATIENTS: A SINGLE CENTRE RETROSPECTIVE STUDY Jyothirmaye Kuppa	Time: 1552 – 1603 AGREEMENT BETWEEN CLINICAL STUDY OUTCOMES AND HOSPITAL ADMINISTRATIVE DATA – THE RANDOMISED EVALUATION OF SODIUM DIALYSATE LEVELS ON VASCULAR EVENTS (RESOLVE) DATA LINKAGE PROJECT Rathika Krishnasamy
		CLINICAL IMPACT OF AN AGE-ADAPTED DEFINITION FOR CHRONIC KIDNEY DISEASE IN OLDER ADULTS Elisa Bongetti	OUTCOMES OF THE OLDER POPULATION WITH ACUTE KIDNEY INJURY REQUIRING RENAL REPLACEMENT THERAPY: A RETROSPECTIVE COHORT STUDY Tracy Li
1600 – 1615	DISCOVERY SCIENCE USING PRECLINICAL MODELS TO IDENTIFY NOVEL MECHANISMS FOR REDUCING CARDIOVASCULAR RISK (FOCUS ON HYPERTENSION) Professor Jacqueline Phillips	AN OBSERVATIONAL REGISTRY BASED STUDY OF TRAJECTORIES AND OUTCOMES OF TREATMENT DECISION MAKING FOR PEOPLE WITH ADVANCED CHRONIC KIDNEY DISEASE IN FRANCE Kathryn Ducharlet	EYE ON AKI – ARE SHIFTING TRENDS THE CUE FOR A PLATFORM CLINICAL TRIAL? Nasir Ali Shah	Time: 1603 – 1614 FRAILTY AS A DETERMINANT OF MORTALITY Limy Wong
		SEX DISPARITIES IN RECEIVING MEDICATIONS IN A GLOBAL COHORT OF PATIENTS WITH CHRONIC KIDNEY DISEASE Rui Du	CURRENT EVIDENCE ON THE TREATMENT OF ACUTE INTERSTITIAL NEPHRITIS: A COMPREHENSIVE REVIEW Yalin Yu	Time: 1614 – 1625 THE CKD-SPICT: PERSONALISED CHOICES IN END STAGE RENAL DISEASE Rachel Frederick
1615 – 1630		PREVALENCE OF CKD IN HOSPITALISED PATIENTS: BASELINE DEMOGRAPHICS FROM A PROSPECTIVE OBSERVATIONAL COHORT STUDY Lucy Wynter	SEX-DRIVEN DIFFERENCES IN THE RENAL INJURY SEVERITY AND RECOVERY DURING AKI-TO-CKD TRANSITION Tingfang Zhang	Time: 1625 – 1636 SIX-WEEKLY VERSUS MONTHLY HAEMODIALYSIS BLOOD TESTING IN AN AUSTRALIAN TERTIARY KIDNEY SERVICE: A QUALITY, SAFETY, GREEN NEPHROLOGY INITIATIVE AND COST-SAVING ANALYSIS Jeffrey Ha
		KNOWLEDGE GAPS IN CHRONIC KIDNEY DISEASE MONITORING AND TREATMENT: A CROSS-SECTIONAL CONSUMER SURVEY STUDY Rushath De Silva	URINARY KIDNEY INJURY MOLECULE (KIM-1) IS AN EARLY BIOMARKER OF CARDIAC SURGERY-ASSOCIATED ACUTE KIDNEY INJURY (CSA-AKI): A SINGLE CENTRE PROSPECTIVE COHORT STUDY Aditya Verma
1630 – 1645	UPDATE ON HYPERTENSION FOR NEPHROLOGISTS A/Prof. Damon Bell	TIME-LAG FOR CHRONIC KIDNEY DISEASE RANDOMISED CONTROLLED TRIAL INCORPORATION INTO NEPHROLOGY GUIDELINES Brydee Anna Cashmore	SELECTIVE SORTING OF PROXIMAL TUBULAR CELL SURFACE PROTEINS INTO URINE EXTRACELLULAR VESICLES Chin-Ya Sophie Chiang	Time: 1636 – 1647 RURAL HEALTH IN CRISIS: INVESTIGATING THE PERSISTENT RISE OF CHRONIC KIDNEY DISEASE IN AUSTRALIAN COMMUNITIES Jessica Fraser
		ETHNICITY AND CALD STATUS INFLUENCE MORTALITY AND ACCESS TO TRANSPLANTATION IN AUSTRALIANS RECEIVING KIDNEY REPLACEMENT THERAPY – CALD-KF STUDY Pedro Franca Gois	FAMILIAL ASSOCIATIONS BETWEEN ANCA-ASSOCIATED VASCULITIS AND OTHER AUTOIMMUNE DISEASES Justin Chua
1645 – 1700		ASSESSING FRAILTY USING THE SHORT PHYSICAL PERFORMANCE BATTERY IN KIDNEY TRANSPLANT CANDIDATES Clare Leslie	THE AAV-PRO CORRELATES WITH QUALITY OF LIFE MEASURES AND ADDS TO THE ASSESSMENT OF AUSTRALIAN ANCA-ASSOCIATED VASCULITIS OUTPATIENTS Ajinkya Bhonsle	Time: 1647 – 1658 COMPARATIVE EVALUATION OF TRAPEZOID AND BAYESIAN METHODS FOR MYCOPHENOLIC ACID AUC ESTIMATION AND LONG-TERM EXPOSURE IN KIDNEY TRANSPLANT PATIENTS Sonia Sharma
		Mini Oral Buffer	Mini Oral Buffer
1700 – 1800	ANZSN AGM \| Meeting Room 8, Level 2 , PCEC
1800 – 1900	Research & Career Opportunity Event \| Meeting Room 1 – 2, Level 2, PCEC
1900 – 2100	yANZSN Networking Event \| Bobeche Cocktail Bar

Tuesday 2nd September 2025

0700 – 0830	Otsuka Breakfast Symposium Breakfast Symposium supported through an Independent Medical Education (IME) grant from Otsuka
Room	Meeting Room 1 – 2
0700 – 0830	Back to the cure: A therapeutic IgA nephropathy time machine Introduction and Welcome to Country Acknowledgment The Past: Consumer’s Journey Dr Nicole Scholes-Robertson, The University of Sydney The Present Professor Jonathan Barratt, University of Leicester The Future Dr Adrian Liew, Mount Elizabeth Novena Hospital Panel Discussion Moderator: Muh Geot Wong Dr Nicole Scholes Robertson, The University of Sydney Prof. Jonanthan Barratt, University of Leicester Dr Adrian Liew, Mount Elizabeth Novena Hospital Prof. Liz Lightstone, Imperial College London
0815 – 1930	Registration
0845 – 1000	PLENARY #3
Room	BelleVue Ballroom 2
Session Chair/s	Professor Rob Walker
0845 – 0900	DAY 2 WELCOME
0900 – 1000	Plenary Speaker CULTURAL SAFETY MAKES US ALL BETTER CLINICIANS Dr Apisalome (Api) Talemaitoga, Normans Road Surgery, Christchurch
1000 – 1030	Morning Tea, Exhibition and Poster Viewing
1030 – 1200	CONCURRENT SESSION #3
Stream	Symposium – Consumers	Shaun Summers Clinical Trainee Award Session	Discovery & Translational Science Award Session	Mini Orals: Transplantation
Room	BelleVue Ballroom 2	Meeting Room 1	Meeting Room 2	Meeting Room 3
Session Chair/s	Dr Nicole Scholes-Robertson & Ashton Kline	A/Prof. Janak De Zoysa & Dr Georgina Irish	Prof. Jacqueline Phillips & Dr Jantina Manning	A/Prof. Angus Ritchie & Dr Lisa Jeffs
1030 – 1045	NIKTT AND COMPASS UPDATE Kelli Owen Richard Jenkins Leanne Taylor Uncle Dunbar Nunju	EVALUATING THE ACCURACY AND COMPLETENESS OF ANZDATA RECORDED CAUSE OF DEATH AMONGST TRANSPLANT RECIPIENTS Melissa Levy	Time: 1030 – 1041 IDENTIFICATION OF MONK AS A CRITICAL MEDIATOR OF GLOMERULONEPHRITIS AND A NOVEL THERAPEUTIC TARGET Simon Jiang	CYSTATIN-C AND KIM-1 RISES WITH POTENTIAL CALCINEURIN-INHIBITOR NEPHROTOXICITY FOLLOWING KIDNEY TRANSPLANTATION Vincent Go
1030 – 1045		WAITLISTING AND TRANSPLANTATION OUTCOMES FOLLOWING CORONARY ARTERY BYPASS GRAFTING: A NATIONAL DATA LINKAGE STUDY Zena Barakat	Time: 1041 – 1052 RELB VARIANTS CAN DRIVE TGF-B MEDIATED RENAL FIBROSIS Justin Chan Hsian Loon	VARIATION IN LIVING KIDNEY DONATION BY TRANSPLANT REFERRAL REGION: A BINIATIONAL ANALYSIS Melanie Wyld
1045 – 1100		TRENDS IN LOWER LIMB AMPUTATION RATES AMONG PATIENTS RECEIVING CHRONIC KIDNEY REPLACEMENT THERAPY: 15-YEAR EXPERIENCE ACROSS AUSTRALIA AND NEW ZEALAND Kanzool Hasan	Time: 1052 – 1103 LATENT CMV INFECTION ENHANCES EXPERIMENTAL ANTI-MPO AUTOIMMUNITY AND RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS A. Richard Kitching	IMPROVING LIVING KIDNEY DONOR SOLICITATION: A SYSTEMATIC REVIEW AND META-ANALYSIS OF INTERVENTIONS Melanie Wyld
1045 – 1100		IMPACT OF PREOPERATIVE HAEMOGLOBIN ON OUTCOMES IN PATIENTS WITH CHRONIC AND END-STAGE KIDNEY DISEASE UNDERGOING CARDIAC SURGERY ON CARDIOPULMONARY BYPASS Siaw Wee Teo		VARIABILITY IN CARDIOVASCULAR AND METABOLIC ASSESSMENT OF LIVING KIDNEY DONORS: A NATIONAL SURVEY OF AUSTRALIAN NEPHROLOGISTS Melanie Wyld
1100 – 1115	KIDNEY HEALTH AUSTRALIA UPDATE Chris Forbes Breonny Robson	PARATHYROIDECTOMY RATES AND POST-OPERATIVE MORTALITY IN PATIENTS ON KIDNEY REPLACEMENT THERAPY IN AUSTRALIA AND NEW ZEALAND Phoebe Tin	Time: 1103 – 1114 IN PR3-ANCA-ASSOCIATED VASCULITIS (PR3-AAV), THE NEPHRITOGENIC CD4+ T CELL HUMAN PR3 EPITOPE EXHIBITS UNIQUE HLA BINDING PROPERTIES Lani Shochet	LIVING KIDNEY DONOR EVALUATION IN AUSTRALIA: A NATIONAL SURVEY OF GUIDELINE AVAILABILITY AND USE Melanie Wyld
1100 – 1115		CALD STATUS AND DIALYSIS WITHDRAWAL IN AUSTRALIA Kate Brotherton	Time: 1114 – 1125 MICRORNA BIOMARKERS OF TUBULAR FERROPTOSIS PREDICT ACUTE KIDNEY INJURY PROGRESSION Andrew Kassianos	INSIDER KNOWLEDGE FROM HIGHLY ACTIVE TRANSPLANT RECIPIENTS: LESSONS FOR HELPING MORE PEOPLE BECOME ACTIVE Kelly Lambert
1115 – 1130	SONG-LIFE PARTICIPATION – KIDS Anastasia Hughes Chandana Guha	FACILITATORS AND BARRIERS TO SCHOOL ATTENDANCE IN CHILDREN WITH CKD: A CROSS-SECTIONAL SURVEY Kriscara Singh	Time: 1125 – 1136 NOVEL MOLECULAR URINARY BIOMARKERS IN PRE-ECLAMPSIA Vanessa Heron	HUMAN METAPNEUMOVIRUS IN KIDNEY TRANSPLANT RECIPIENTS: A SYSTEMATIC REVIEW Henry HL Wu
1115 – 1130		PREVALENCE AND SCREENING OF CARDIOVASCULAR RISK FACTORS IN CHILDREN WITH ADVANCED CHRONIC KIDNEY DISEASE Sarah Marokakis		“I WANT GOOD KIDNEYS GOING TO YOUNG PEOPLE AND GOOD ENOUGH KIDNEYS GOING TO OLDER PEOPLE”: NEPHROLOGIST VIEWS ON PROGNOSIS MATCHING IN DECEASED DONOR KIDNEY TRANSPLANT ALLOCATION Alison Weightman
1130 – 1145	LONELINESS AND SOCIAL ISOLATION Amanda Sluiter	Shaun Summers Buffer	Time: 1136 – 1147 OBESITY INCREASES NECROPTOSIS TO EXACERBATE ACUTE KIDNEY INJURY IN FOLIC ACID NEPHROPATHY Peter Mount	INTERIM RESULTS OF THE SURVEY OF TREATMENT APPROACHES AFTER GRAFT FAILURE IN AUSTRALIA AND NEW ZEALAND (STAG-ANZ) Helena Xiang
1130 – 1145	LONELINESS AND SOCIAL ISOLATION Amanda Sluiter	Shaun Summers Buffer		INCREASED LEVELS OF RENAL GLYCOLYSIS REGULATORS IN URINARY EXTRACELLULAR VESICLES WITH KIDNEY TRANSPLANT REJECTION AND ISCHAEMIA-REPERFUSION PY Mia Leung
1145 – 1200	Question time & Consumer and Carer Day Workshop Feedback		Time: 1147 – 1158 MULTI-OMIC SIGNATURE OF URINE EXTRACELLULAR VESICLES FROM PEOPLE WITH CHRONIC KIDNEY DISEASE Monica Suet Ying Ng	TOWARDS SYSTEM CHANGE: HOW DO WE EMBED COMMUNITY PRIORITIES INTO NATIONAL TRANSPLANTATION POLICY? Stephen McDonald Jaquelyne Hughes
1145 – 1200				Mini Oral Buffer
1200 – 1300	Lunch, Exhibition and Poster Viewing
1215 – 1245	Novartis Knowledge Hub Presentation \| BelleVue Room 1 Cracking the Silence of C3G: Uncovering Complexity and Rewriting the Future of C3G Dr Sharon Ford, Prof Carol Pollock, A/Prof Angus Ritchie C3 glomerulopathy (C3G) is an ultra-rare, underdiagnosed and progressive kidney disease driven by dysregulation of the alternative complement pathway. Its heterogenous clinical presentation and histopathological overlap with other glomerular diseases contribute to diagnostic uncertainty and misclassification. This session explores the pathophysiological underpinnings of C3G and the diagnostic challenges faced in routine nephrology practice, including biopsy interpretation and complement biomarker assessment. Recent evidence is reshaping our understanding of disease trajectory and informing the development of targeted approaches that address the root cause of complement overactivation. Attendees will gain practical insights to improve diagnostic precision and optimise clinical management in patients with C3G.
1300 – 1355	PLENARY #4
Room	BelleVue Ballroom 2
Session Chair/s	Dr Erin Vaughan
1300 – 1355	Plenary Speaker WOMEN’S HEALTH AND KIDNEY DISEASE – A GLOBAL PERSPECTIVE Professor Liz Lightstone, Imperial College London
1355	Move to concurrent rooms
1400 – 1500	CONCURRENT SESSION #4
Stream	Mini Orals: Nutrition	Mini Orals: General Nephrology – Pregnancy Associated, Peritoneal Dialysis & Kidney Supportive Care	Mini Orals: Paediatrics	Mini Orals: Quality Indicators and Improvement & General Nephrology – Other
Room	Meeting Room 1	Meeting Room 2	Meeting Room 3	Meeting Room 8
Session Chair/s	Anthony Meade & Dr Nicharee Sandurn	Dr Arunima Jain & Lenny Jacoby	Dr Siah Kim & Dr Madeleine Didsbury	Dr Jayana Devathasan & Prof. Sandawana William Majoni
1400 – 1415	IS DIGITAL HEALTH AN ACCEPTABLE PLATFORM TO DELIVER DIETARY PHOSPHORUS ADVICE IN PATIENTS ON DIALYSIS? USING THE VALIDATED MHEALTH APP USABILITY QUESTIONNAIRE TO PROVIDE THE ANSWER. Joanne Beer	THE ANGIOGENIC RATIO FOR PREDICTION OF PREECLAMPSIA (ARPP) AND ITS USE IN PATIENTS WITH CHRONIC HYPERTENSION (ARPP-HTN) Harsha Suresh	EPIDEMIOLOGY AND OUTCOME OF ACUTE KIDNEY INJURY IN A QUATERNARY REFERRAL NEONATAL INTENSIVE CARE UNIT Thomas Forbes	CHANGING SURVIVAL OF END STAGE KIDNEY DISEASE SECONDARY TO AMYLOIDOSIS IN THE AUSTRALIAN AND NEW ZEALAND POPULATION Prudence Gregory
1400 – 1415	PERFORMANCE OF THE MALNUTRITION SCREENING TOOL (MST) IN DETECTING MALNUTRITION AMONG OUTPATIENTS WITH CHRONIC KIDNEY DISEASE (CKD) WITHOUT KIDNEY REPLACEMENT THERAPY (KRT) Maria Chan	THE ANGIOGENIC RATIO FOR PREDICTION OF PREECLAMPSIA (ARPP) AND ITS USE IN PATIENTS WITH CHRONIC KIDNEY DISEASE (ARPP-CKD) Andrea Huang	IDENTIFYING STRATEGIES TO IMPROVE LIFE PARTICIPATION IN CHILDREN WITH CHRONIC KIDNEY DISEASE: REPORT FROM MULTINATIONAL WORKSHOPS Anastasia Hughes	EVALUATING CONCORDANCE OF CLINICAL OUTCOMES IN REGISTRY AND HOSPITAL ADMINISTRATIVE DATA COMPARED WITH AUDITED MEDICAL CHART REVIEW IN A SINGLE CENTRE Neeru Agarwal
1415 – 1430	PERCEPTIONS AND PRACTICES OF DIETARY MANAGEMENT IN POLYCYSTIC KIDNEY DISEASE: A SURVEY OF RENAL HEALTHCARE PROFESSIONALS IN AUSTRALIA Jessica Dawson	TRAINING AND CONFIDENCE IN WOMEN’S HEALTH AND OBSTETRIC NEPHROLOGY: A NATIONAL SURVEY OF AUSTRALIAN NEPHROLOGY TRAINEES AND EARLY-CAREER FELLOWS Melanie Wyld	ESTABLISHING A CORE OUTCOME MEASURE FOR LIFE PARTICIPATION IN CHILDREN WITH CHRONIC KIDNEY DISEASE: A STANDARDISED OUTCOMES IN NEPHROLOGY – CHILDREN AND ADOLESCENTS WITH CHRONIC KIDNEY DISEASE (SONG-CKD) CONSENSUS WORKSHOP REPORT Anastasia Hughes Allison Jaure	ETHNICITY DATA REPORTING IN PEOPLE WITH KIDNEY FAILURE IN AOTEAROA NEW ZEALAND: A CLINICAL QUALITY AUDIT Jackie Lee Hazelhurst
1415 – 1430	PERSPECTIVES AND PRACTICES OF PEOPLE LIVING WITH POLYCYSTIC KIDNEY DISEASE REGARDING DIETARY AND FLUID MANAGEMENT Jessica Dawson	NEPHROLOGIST PERSPECTIVES ON NAVIGATING CONCEPTION AND PREGNANCY IN WOMEN WITH KIDNEY DISEASE: A SEMI-STRUCTURED INTERVIEW STUDY Melanie Wyld	NEW ONSET DIABETES IN PAEDIATRIC RENAL TRANSPLANT RECIPIENTS Harleen Kaur	ASEPTIC NON-TOUCH TECHNIQUE (ANTT) TO HAEMODIALYSIS CATHETER ACCESS – A SINGLE-CENTRE EXPERIENCE Maggie-Rose Bayliss
1430 – 1445	TASTE PREFRENCES OF PEOPLE WITH CHRONIC KIDNEY DISEASE WITHOUT KIDNEY REPLACEMENT THERAPY: PRELIMINARY FINDINGS Kelly Lambert	OVERCOMING THE “BAD STORY ABOUT TUMMY DIALYSIS”: THE PERSPECTIVES OF CLINICIANS IN CENTRAL AUSTRALIA ON ACCESS TO PERITONEAL DIALYSIS Nicole Scholes-Robertson	FACILITATORS AND BARRIERS TO SPORT PARTICIPATION IN CHILDREN WITH CKD: A CROSS SECTIONAL SURVEY Pak Yan Yue	A PHASE 1A CLINICAL TRIAL OF PYC-003 FOR THE TREATMENT OF PATIENTS WITH AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD) Aron Chakera
1430 – 1445	“MATE, I’M NOT HAVING ENOUGH VEGGIES!”: EVALUATING THE FEASIBILITY AND ACCEPTABILITY OF THE KIDNEY-HEALTHY EATING AND LIFESTYLE PROGRAM (KIDNEY-HELP) Erynn McAuley	CALD STATUS AND GEOGRAPHIC DISPARITIES IN INITIAL KIDNEY REPLACEMENT THERAPY MODALITY IN AUSTRALIA: INSIGHTS FROM THE CALD-KF STUDY Pedro Franca Gois	IN NEW SOUTH WALES, CALCINEURIN INHIBITORS ARE THE PREDOMINANT SECOND LINE AGENT OF CHOICE IN CHILDHOOD STEROID SENSITIVE NEPHROTIC SYNDROME Hugh McCarthy	RENAL COMPLICATIONS OF SICKLE CELL DISEASE IN AN AUSTRALIAN COHORT Louise Keamy
1445 – 1500	INVESTIGATING THE USE OF DIETARY INTERVENTIONS FOR THE MANAGEMENT OF AUTOSOMAL-DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD) THROUGH KETOSIS: A SYSTEMATIC REVIEW Mia Abdy	UNDERSTANDING ENGAGEMENT WITH ADVANCE CARE PLANNING FOR PEOPLE WITH RENAL DISEASE AND RECOMMENDATIONS FOR HOW TO IMPROVE PATIENT EXPERIENCES: A QUALITATIVE STUDY Kathryn Ducharlet	VARIABILITY IN STEROID PRESCRIPTION IN THE MANAGEMENT OF PAEDIATRIC NEPHROTIC SYNDROME IN NEW SOUTH WALES: A RETROSPECTIVE MEDICAL RECORDS REVIEW Thomas Veitch	HEPATITIS B VACCINATION FOR PATIENTS WITH STAGE 4 CHRONIC KIDNEY DISEASE – RESPONSE AND AFFECTING FACTORS: A PROSPECTIVE STUDY Casey Light
1445 – 1500	IMPACT OF ZINC SUPPLEMENTATION ON NUTRITION-RELATED OUTCOMES IN ADULTS WITH CHRONIC KIDNEY DISEASE Natalie Li Xuan Tan Jessica Dawson	EVALUATION OF THE DOUBLE SURPRISE QUESTION TO PREDICT MORTALITY AMONG PEOPLE RECEIVING HAEMODIALYSIS OR PERITONEAL DIALYSIS Daniel Vincent O’Hara		ESTABLISHING A CO-CULTURE SYSTEM TO IDENTIFY KEY PARACRINE AND ENDOCRINE INTERACTIONS BETWEEN MYOBLASTS AND OSTEOBLASTS Limy Wong
1500 – 1530	Afternoon Tea, Exhibition and Poster Viewing
1530 – 1700	CONCURRENT SESSION #5
Stream	Symposium – Pacific Health Advancement	Symposium – Equity, Diversity, Inclusion and Actions- a set of conversations.	Symposium – Infections and Renal Health *Infections and Renal Health: Strategies for Prevention and Management in Aotearoa and Australia*	Symposium – ANZDATA
Room	Meeting Room 1	Meeting Room 2	Meeting Room 3	Meeting Room 8
Session Chair/s	Professors Rob Walker & Shilpa Jesudason	Dr Sadia Jahan & Dr Rebecca Hudson	Dr Adam Flavell & Dr Kushani Jayasinghe	A/Prof. Sradha Kotwal & Dr Dana Forcey
1530 – 1600	Time: 1530 – 1550 WELCOME AND OPENING Professor Rob Walker PROGRESS AND STRATEGY: UPDATES FROM THE ANZSN PACIFIC WORKING GROUP Professor Shilpa Jesudason	PERSPECTIVES ON EDI : IMPACT ON CLINICAL AND RESEARCH ACTIVITIES. Professor Adeera Levin, University of British Columbia Dr Melanie Wyld	PREDICTING AND PREVENTING INFECTIONS IN TRANSPLANT RECIPIENTS (AND OTHER IMMUNOSUPPRESSED PATIENTS) Dr Bradley Gardiner	Time: 1535 – 1550 PAST: HISTORY & IMPACT OF ANZDATA Professor Stephen McDonald
1600 – 1630	Time: 1550 – 1640 PACIFIC PERSPECTIVES ON KIDNEY HEALTH SPEAKERS Dr Apisalome (Api) Talemaitoga, Normans Road Surgery, Christchurch. Nephrology leaders from Fiji, Samoa and Papua New Guinea (V) Dr Yogeshni Chandra (Fiji) Dr Ben Matalavea (Samoa) Dr Lama Tufana’l (Samoa) TBA (Papua New Guinea)		PD-RELATED INFECTION BEYOND PD PERITONITIS Dr Jenny Chen	Time 1550 – 1615 PRESENT: CAPACITY & DIVERSE USE A/Prof. Sradha Kotwal Dr Dana Forcey Dr Kate Brotherton Time: 1615 – 1635 FUTURE: INNOVATION & VISION Dr Georgina Irish
1630 – 1700	Time: 1640 – 1700 PANEL DISCUSSION	SOVEREIGNTY EXERCISED BY AND FOR TORRES STRAIT ISLANDER PEOPLES Prof Jaqui Hughes	CASE BASED DISCUSSIONS Dr Prudence Gregory Dr Isra Iftikhar Dr Zena Barakat	Time: 1635 – 1655 PANEL DISCUSSION Moderator – A/Prof. Sradha Kotwal
Room	Meeting Room 1			Meeting Room 8
Session Chair/s	Prof. Andrew Mallett			Dr Sharon Ford
1700 – 1730	Genomics in Nephrology – mainstreaming, multidisciplinary clinics, or something else? Panel of International Kidgen guests and local speakers			Time: 1700 – 1720 TSANZ: Deceased Kidney Allocation Algorithm Phillip Clayton, ANZDATA
1700 – 1730				Time: 1720 – 1730 NIKTT Data Dashboard Prof. Jaqui Hughes Stephen McDonald
1900 till late	Gala Dinner \| BelleVue Ballroom 2, Level 3, PCEC

Wednesday 3rd September 2025

0700 – 0830	KDIGO Breakfast Symposium
Room	Meeting Room 1 – 2
	Precision Medicine in IgAN Treatment: Selecting the Right Therapies for the Right Patient at the Right Time A discussion around the new KDIGO 2025 IgAN Guideline Update. A/Prof. Muh Geot Wong, Concord Repatriation General Hospital Meg Jardine, NHMRC Clinical Trials Centre, Faculty Of Medicine, University Of Sydney
0830 – 1500	Registration
0830 – 0900	PLENARY SESSION #5: ACHIEVE Trial Session
Room	BelleVue Ballroom 2
Session Chair/s	Professor Rathika Krishnasamy
0830 – 0900	ACHIEVE Trial Session Janak De Zoysa, Martin Gallagher, and Michael Walsh
0900	Move to concurrent rooms
0900 – 1030	CONCURRENT SESSION #6
Stream	Symposium – Aboriginal, Torres Strait Islander, Māori Health	Symposium – AKTN/CARI	Symposium – Kidney Biomarkers for Personalised Precision Medicine	Symposium – Kidney Supportive Care *KSC provision for regional and remote Australia and New Zealand*
Room	BelleVue Ballroom 2	Meeting Room 1	Meeting Room 2	Meeting Room 3
Session Chair/s	Dr Luke Wilson & Dr Julian Conboy	A/Prof. Yeoungjee Cho & A/Prof. Vincent Lee	Dr Mia Leung & Dr Jantina Manning	Dr Ciara Robinson & Dr Kirsten Hepburn
0900 – 0915	Introduction and Welcome	WELCOME Yeoungjee Cho	WHAT CAN TUBULAR INJURY BIOMARKERS TELL US ABOUT ACUTE KIDNEY INJURY? Prof Rob Walker	CASE 1: HEALING IN FAREWELL: COORDINATED END-OF-LIFE CARE FOR AN ABORIGINAL PATIENT RETURNING TO COUNTRY Steph Barrett Kerry Howell Dr Dorit Lesterhuis-Vasbinder Dr Rebecca Hudson
	A TORRES STRAIT COMMUNITY-DEVELOPMENT PROJECT TO RESTORE KIDNEY HEALTH AND OVERCOME DEATH FROM KIDNEY FAILURE AND ITS RELATED CONDITIONS: KIKIRRIU DAN WALMAI PROJECT Jaquelyne T Hughes Karla K Canuto	Time: 0905 – 0925 NEW DIRECTIONS FOR AKTN: HOW WE PLAN TO GENERATE AND RECEIVE NEW IDEAS FOR HIGH PRIORITY, HIGH QUALITY AND PRAGMATIC TRIALS Prof Rathika Krishnasamy
0915 – 0930	FROM COMMUNITY TO CLINICIAN: IMPROVING KIDNEY HEALTH RESEARCH PRACTICE Catherine Scotney	Time: 0925 – 0935 TRIAL DEVELOPMENT (IMPEDE PKD) Prof Andrew Mallett	HARNESSING THE POWER OF RNA/DNA BIOMARKERS FOR KIDNEY TRANSPLANT CARE Dr Jennifer Li
0930 – 0945	HOW PATIENT NAVIGATORS CAN IMPROVE THE CULTURAL SAFETY AND RESPONSIVENESS OF HEALTHCARE SYSTEMS FOR ABORIGINAL AND TORRES STRAIT ISLANDER PEOPLE WITH KIDNEY FAILURE: THE COMPASS PROJECT Isabelle Haklar Kelli Karrikarringka Owen	Time: 0935 – 1005 COCHRANE REVIEW – THE EFFICACY AND SAFETY OF INTERVENTIONS IN AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE Dr David Tunnicliffe DIETARY REVIEW Mia Abdy GUIDELINE AND COMMENTARY A/Prof Vincent Lee CARI UPDATE – IMPROVING THE RELEVANCE OF CLINICAL GUIDELINES IN KIDNEY DISEASE Dr David Tunnicliffe		CASE 2: COMPLEXITIES OF DIAGNOSIS AND PAIN MANAGEMENT IN A REGIONAL RENAL TRANSPLANT PATIENT Dr Lisa Jeffs A/Prof Sampath Kondasinghe
0945 – 1000	IMPROVING KIDNEY CARE FOR NYIYAPARLI COMMUNITIES: A CO-DESIGNED, CULTURALLY SAFE APPROACH Rose Whitau Soraya Daniels		EXTRACELLULAR VESICLES AS DIAGNOSTIC TOOLS Dr Monica Ng
1000 – 1015	IMPROVING THE PATIENT JOURNEY IN CENTRAL AUSTRALIA: INVESTIGATING THE MODIFIABLE FACTORS AFFECTING THE DIALYSIS ATTENDANCE TO CO-DESIGN EFFECTIVE SUPPORT PATHWAYS Sajith Kesavan Nayar	Time: 1005 – 1030 Q&A PANEL Moderator: A/Prof Vincent Lee	PANEL DISCUSSION Moderators: Dr Mia Leung & Dr Jantina Manning	PANEL DISCUSSION Steph Barrett Kerry Howell Dr Dorit Lesterhuis-Vasbinder Dr Rebecca Hudson Dr Lisa Jeffs A/Prof Sampath Kondasinghe
1015 – 1030	Summary and Conclusion
1030 – 1100	Morning Tea, Exhibition and Poster Viewing
1100 – 1230	CONCURRENT SESSION #7
Stream	Symposium – Sustainable Healthcare	Symposium – Adolescent and Young Adult	Mini Orals: General Nephrology – Epidemiology and Public Health, Developmental Biology & Genetics	Mini Orals: General Nephrology – Diabetes/Cardiovascular/Hypertension & Glomerulonephritis
Rooms	BelleVue Ballroom 2	Meeting Room 1	Meeting Room 2	Meeting Room 3
Session Chair/s	A/Prof. Kelly Lambert & Dr Shaundeep Sen	Dr Jacqueline Soraru & Dr Hugh McCarthy	Dr Jeffrey Ha & Dr Rachel Elliott	Dr Andrew Sunderland & Dr Priyanka Sagar
1100 – 1115	THE POWER OF PREVENTION: SUSTAINABLE KIDNEY RESEARCH Dr Benjamin Talbot, The George Institute	Time: 11:00 – 11:20 THE ANZ BLOOD PRESSURE GUIDELINE FOR ADOLESCENTS Dr Sheena Kaul	CARDIOVASCULAR MORTALITY IN CKD: DO RISK FACTORS DIFFER BY SEX? Hannah Tayla Belikoff	PRESCRIBING OF RENAL AND CARDIOVASCULAR PROTECTIVE THERAPIES IN TYPE 2 DIABETES AND CHRONIC KIDNEY DISEASE: AUDIT OF AN AUSTRALIAN QUATERNARY HOSPITAL Nick S. R. Lan
			PRIORITISED ANCA-ASSOCIATED VASCULITIS OUTCOMES FOR REPORTING FROM THE AUSTRALIA AND NEW ZEALAND VASCULITIS REGISTRY DETERMINED BY PATIENT-CLINICIAN CONSENSUS Justin Chua	IMPACT OF DIABETES, ALBUMINURIA, ACUTE EGFR DIP, AND DISEASE SEVERITY ON THE EFFECTS OF EMPAGLIFLOZIN ON PROGRESSION OF CHRONIC KIDNEY DISEASE Bobby Chacko
1115 – 1130		Time: 11:20 – 11:40 KDIGO 2024 UPDATE ON THE MANAGEMENT OF CKD FOR ADOLESCENTS Dr Kriscara Singh	LONG-TERM PATIENT AND GRAFT SURVIVAL FOLLOWING CARDIAC SURGERY FOR PEOPLE RECEIVING KIDNEY REPLACEMENT THERAPY: A NATIONAL DATA LINKAGE STUDY Christopher Davies	VICADROSTAT WITH AND WITHOUT EMPAGLIFLOZIN REDUCES ALBUMINURIA ACROSS KDIGO RISK CLASS IN CHRONIC KIDNEY DISEASE Bobby Chacko
			WEATHERING THE STORM: IMPACT OF CYCLONE ALFRED ON DIALYSIS CARE AND EMERGENCY PLANNING Archee Singh	EFFECTS OF VICADROSTAT WITH AND WITHOUT EMPAGLIFLOZIN IN PEOPLE WITH CHRONIC KIDNEY DISEASE BY BASELINE BODY MASS INDEX Bobby Chacko
1130 – 1145	GREEN DIALYSIS PRESCRIPTIONS Dr Giorgina Piccoli (V) Le Mans Hospital (France)	Time: 11:40 – 12:10 BELATACEPT PROVIDES AN EFFECTIVE ALTERNATIVE IMMUNOSUPPRESSION FOR NON-COMPLIANT TRANSPLANT RECIPIENTS – A DEBATE Dr Siah Kim and Dr Erin Vaughan	EPIDEMIOLOGY OF URINARY TRACT CALCULI IN AUSTRALIA FROM 2003 TO 2023 Hilary Hiscock	ASSOCIATION BETWEEN INSULIN USE AND SURGICAL OUTCOMES IN DIABETIC KIDNEY REPLACEMENT THERAPY RECIPIENTS: A BI-NATIONAL DATA-LINKAGE STUDY Mina Khair
			SEX-RELATED DIFFERENCES IN CHRONIC KIDNEY DISEASE MONITORING AND CARDIOVASCULAR RISK MANAGEMENT IN AUSTRALIAN PRIMARY CARE: A RETROSPECTIVE COHORT STUDY Hannah Wallace	NEDD4-2 ABLATION IN KIDNEY IMPROVES GLYCAEMIC CONTROL IN DIABETIC MICE Jantina Manning
1145 – 1200			AGE-STANDARDISED PREVALENCE OF DIABETES, CHRONIC KIDNEY DISEASE AND CARDIOVASCULAR DISEASE IN MELBOURNE’S WEST Hannah Wallace	NON-DIABETIC KIDNEY DISEASE IN PATIENTS WITH DIABETES UNDERGOING KIDNEY BIOPSY Rizza Antoinette Yap So
			CLINICAL OUTCOMES AND PATIENT SATISFACTION OF A NURSE PRACTITIONER CHRONIC KIDNEY DISEASE CLINIC Hannah Wallace	ASTRAGALOSIDE IV RESTORES AUTOPHAGY AND INHIBITS APOPTOSIS FOR PODOCYTE PROTECTION IN DIABETIC NEPHROPATHY BY INHIBITING THE NOTCH1 SIGNALING VIA SIRT6-MEDIATED DEACETYLATION Qiyu Yue
1200 – 1215	Time: 1200 – 1210 SUSTAINABLE HEALTHCARE QUIZ Dr Shaundeep Sen Time: 1210 – 1220 WASTE REDUCTION IN DIALYSIS Dr Anoushka Krishnan Time: 1220 – 1230 CENTRAL ACID DELIVERY Dr Jane Waugh	Time: 12:10 – 12:30 ADPKD IN CHILDREN: WHAT PROSPECTIVE PARENTS WITH ADPKD SHOULD KNOW Dr Hugh McCarthy	PATTERNS OF COMORBIDITY AND DISABILITY IN NEPHROLOGY: INFORMING A ROADMAP FOR EFFECTIVE FRAILTY CARE Thái Bình Trần	INCREASED URINARY EXTRACELLULAR VESICLES AND REDUCED EXPRESSION OF NEDD4L IN DIABETIC NEPHROPATHY – A PILOT STUDY Nikhil Thyagarajan
			BLOCKING ENGRAILED-1 (EN-1) EXPRESSION INHIBITS RENAL FIBROBLAST ACTIVATION IN A MODEL OF KIDNEY FIBROSIS Wenyang Shi	HIGH-RESOLUTION SPATIAL TRANSCRIPTOMICS REVEALS TUBULAR SEGMENT-SPECIFIC PRO-INFLAMMATORY PATHWAYS OF FUNCTIONAL LOSS IN IGA NEPHROPATHY Benjamin Adams
1215 – 1230			PKD1 5’UTR VARIANTS ARE A RARE CAUSE OF DISEASE IN AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD) AND SUGGEST AN AVENUE FOR INCREASING POLYCYSTIN-1 EXPRESSION Amali Mallawaarachchi	RENAL PATHOLOGY IN HIV-PATIENTS: INSIGHTS FROM A SINGLE-CENTER STUDY IN JAPAN Sakamoto Emi
			Mini Oral Buffer	Mini Oral Buffer
1230 – 1330	Lunch, Exhibition and Poster Viewing
1330 – 1500	PLENARY #6: Awards & Closing
Room	BelleVue Ballroom 2
Session Chair/s	Dr Sharon Ford
1330 – 1400	Jacquot Fellowships – Research Established Presentation Professor Andrew Mallett
1400 – 1425	Jacquot Fellowships – Research Entry Presentation Dr Jennifer Yo
1425 – 1440	Unsung Hero Award Associate Professor Angus Ritchie
1440 – 1500	President’s Closing Comments and Handover to 2026
1500	Airport shuttle bus commences from the front of the PCEC